Beam Therapeutics Inc. P/S ratio

P/S ratio of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/S ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its sales per share. It is used by investors mainly because it’s less volatile than P/E and less subject to accounting manipulation. A low P/S ratio compare to historical average or other companies in the same industry might indicate undervaluation.

Highlights and Quick Summary

Current P/S ratio of Beam Therapeutics Inc. is 98.73 (as of December 31, 2021)
  • P/S ratio for the quarter ending September 30, 2022 was 36.44 (a 3.14% increase compared to previous quarter)
  • Year-over-year quarterly P/S ratio decreased by -63.08%
  • Annual P/S ratio for 2021 was 98.73 (a -99.94% decrease from previous year)
  • Annual P/S ratio for 2020 was 158970.77 (a Infinity% increase from previous year)
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/S ratio of Beam Therapeutics Inc.

Most recent P/S ratioof BEAM including historical data for past 10 years.

Interactive Chart of P/S ratio of Beam Therapeutics Inc.

Beam Therapeutics Inc. P/S ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 36.44 35.34 65.32 –
2021 98.73 7395.03 333628.12 200800.68 98.73
2020 158970.77 51381.73 57668.45 23043.83 158970.77
2019 0.0 0.0 0.0 – 0.0

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com